PAOLO TEMPONGKO, MD
Rheumatology Physician · ATLANTIC CITY, NJ
Individual Active NPI 1548781644
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 682 | 197,270 | $10,794,219 | $4,574,649 | $3,629,272 |
| 2023 | 387 | 70,108 | $3,431,886 | $1,366,054 | $1,087,647 |
| 2022 | 29 | 180 | $22,386 | $11,503 | $9,165 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 93,604 | $5 | $4 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 26,464 | $11 | $9 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 24,054 | $11 | $9 |
| J0897 | Injection, denosumab, 1 mg | 12,487 | $26 | $21 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,779 | $42 | $34 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 2,409 | $0 | $0 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 1,066 | $17 | $13 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 962 | $77 | $58 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 807 | $134 | $97 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 485 | $140 | $104 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 435 | $189 | $150 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 259 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Rheumatology Physician | 207RR0500X | ✓ | 25MA11615700 | NJ |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Rheumatology Physician providers in New Jersey
- NPI 1912296278
- NPI 1417994633
- NPI 1487272043
- NPI 1134642994
- NPI 1659775344
- NPI 1821456187
- NPI 1447622303
- NPI 1023412111
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.